CAMBRIDGE, Mass., Sept. 6, 2022 (GLOBE NEWSWIRE) — Cerevel Therapeutics, CEREa company dedicated to unlocking the mysteries of the brain to treat neuroscientific diseases announced that members of its management team will attend Morgan Stanley 20th Annual Global Healthcare Conference on Monday, September 12, 2022. Chairman and Chief Executive Officer Tony Coles, MD will participate in a fireside chat at 9:20 am ET.
The live webcast of the fireside chat can be accessed on the Investor Relations section of Cerevel Therapeutics’ website here. A replay will be available on the same section of the company’s website.
About Cerevel Therapeutics
Cerevel Therapeutics is dedicated to unraveling the mysteries of the brain to treat neuroscientific diseases. The company fights disease with a targeted neuroscience approach that combines expertise in neurocircuitry with a focus on receptor selectivity. Cerevel Therapeutics has a diversified pipeline that includes five clinical-stage investigational therapies and several pre-clinical compounds with the potential to treat a range of neuroscience disorders, including Parkinson’s disease, epilepsy, schizophrenia and dementia-related apathy. Headquartered in Cambridge, Massachusetts, Cerevel Therapeutics advances its current research and development programs while exploring new modalities through internal research efforts, external collaborations or potential acquisitions. For more information visit www.cerevel.com.
Special Note Regarding Forward-Looking Statements
This press release contains forward-looking statements that are based on management’s beliefs and assumptions and on information currently available to management. In some cases, you can identify forward-looking statements by the following words: “may”, “will”, “could”, “would”, “should”, “expect”, “intend”, “plan”, “anticipate”. ,”, “believe,” “estimate,” “predict,” “forecast,” “potential,” “continue,” “ongoing,” or the negative of such terms, or other similar…
